SCHEMBL8320743

SCHEMBL8320743

CCCCCCCCC=CCCCCCCCC(=O)Nc1c(SC)nc(C)nc1SC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.51
SOAT1 P35610 1/20 0.51
PSMB11 A5LHX3 2/20 0.50
PSMA7 O14818 2/20 0.50
PSMB1 P20618 2/20 0.50
PSMA1 P25786 2/20 0.50
PSMA2 P25787 2/20 0.50
PSMA3 P25788 2/20 0.50
PSMA4 P25789 2/20 0.50
PSMB8 P28062 2/20 0.50
PSMB9 P28065 2/20 0.50
PSMA5 P28066 2/20 0.50
PSMB4 P28070 2/20 0.50
PSMB6 P28072 2/20 0.50
PSMB5 P28074 2/20 0.50
PSMB10 P40306 2/20 0.50
PSMB3 P49720 2/20 0.50
PSMB2 P49721 2/20 0.50
PSMA6 P60900 2/20 0.50
PSMA8 Q8TAA3 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8320742 1.00 SOAT2 (0.51) SOAT2SOAT1PSMB11PSMA7PSMB1
SCHEMBL8323141 0.92 CETP (0.43) ALDH1A1HPGDKMT2AFAAHCYP2C19
SCHEMBL8318289 0.92 CETP (0.43) ALDH1A1HPGDKMT2AFAAHCYP2C19
SCHEMBL8324408 0.92 CETP (0.43) ALDH1A1HPGDKMT2AFAAHCYP2C19
SCHEMBL8321117 0.89 SOAT2 (0.50) SOAT2SOAT1PSMB11PSMA7PSMB1
SCHEMBL8321119 0.89 SOAT2 (0.50) SOAT2SOAT1PSMB11PSMA7PSMB1
SCHEMBL9412800 0.85 SOAT2 (0.54) SOAT2SOAT1PSMB11PSMA7PSMB1
SCHEMBL8856278 0.85 SOAT2 (0.54) SOAT2SOAT1PSMB11PSMA7PSMB1
SCHEMBL8325288 0.85 SOAT1 (0.49) SOAT2SOAT1PSMB11PSMA7PSMB1
SCHEMBL8321086 0.85 SOAT1 (0.49) SOAT2SOAT1PSMB11PSMA7PSMB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0609960-B1 New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase PFIZER (US) 1999-03-03 EP claimed
US-5656634-A N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) PFIZER INC. (US) 1997-08-12 US claimed
EP-0609960-A1 New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase PFIZER INC. (US) 1994-08-10 EP claimed
EP-0418071-A2 New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase PFIZER INC. (US) 1991-03-20 EP claimed
EP-0609960-B1 New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase PFIZER (US) 1999-03-03 EP disclosed
US-5656634-A N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) PFIZER INC. (US) 1997-08-12 US disclosed
US-5362878-A Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) PFIZER INC. (US) 1994-11-08 US disclosed
EP-0609960-A1 New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase PFIZER INC. (US) 1994-08-10 EP disclosed
EP-0418071-A2 New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase PFIZER INC. (US) 1991-03-20 EP disclosed